The Victorian Government’s Health Market Validation Program (Health MVP) Call for Proposal stage is now open. The Victorian Government now invites the SME’s to propose new technology solutions to meet the need described in selected TRS.
The Health MVP links those in the public health sector who have identified a technology need with innovative Victorian SMEs that can develop solutions. It supports the pre-market development of innovative healthcare-related products, processes or services by Victorian small to medium sized enterprises (SMEs).
The program builds on an earlier pilot program, developed in consultation with the health industry sector, to effectively target health services.
The Health MVP involves a three-stage process.
| Stage 1 | Stage 2 | Stage 3 |
| Technology Requirement Specifications (TRS)Applications are now closed for health-focused public sector entities to apply for the Health Market Validation Program. | Call for proposal at the second stage, the Victorian Government will invite the SME market to propose new technology solutions to meet the need described in selected TRS. | Feasibility study and validation in stage three, SMEs that submit successful proposals will receive a grant of up to $100,000 to undertake a feasibility study, for up to four months. Successful feasibility studies may then be eligible for further funding of up to $1.5 million over two years in a validation phase to undertake the project R&D (including clinical trials) to progress towards market. Requests for funding above the levels specified may be considered on a case by case basis. |
| Status- Closed | Open: August 2012- 11 Oct 2012 | Late 2012 |
Call for SME Proposals now open
Eligible Small to Medium Enterprises (SME) are invited to review and respond to the healthcare challenges described in the 12 Technology Requirement Specifications (TRS) listed below. To respond to any of the TRS go to guidelines and application form. .
All applications must be received by COB Thursday 11 October 2012
Following assessment of the proposals submitted, the successful SME’s will receive up to $100,000 to undertake a Feasibility Study into their proposed solution.
Technology Requirement Specifications (TRS)
| TRS – Technology Requirement Specification(Click link for more info) | Description |
|
To investigate an early detection method for circulatory shock |
|
To investigate an effective and efficient plaque removal device for children and people with disabilities |
|
To investigate a surgical implant to improve the outcomes of glaucoma surgery |
|
To investigate a device to preserve and extend the quality of a donor organ |
|
To investigate a simple, fast, accurate and low cost nucleic acid detection test of sexually transmitted infections |
|
To investigate a device to make cardiac output and oxygen consumption measurement simpler, safer and more accessible |
|
To investigate a device to measure female hormones at point-of-care |
|
To investigate a real time reporting method allowing CHF patients to report measurements to a central database |
|
To investigate extending a proof-of-concept miniature nebuliser for the treatment of chronic respiratory illnesses |
|
To investigate a venous and arterial cannula that provides both antegrade and retrograde flow/drainage |
|
To investigate more cost-effective and easier Deep Brain Stimulation (DBS) for pain relief in cancer treatment |
|
To investigate an anti-viral treatment for RSV infection |
The aim of the Health Market Validation Program
The Health MVP links those in the public health sector who have identified a technology need with innovative Victorian SMEs that can develop solutions. It supports the pre-market development of innovative healthcare-related products, processes or services by Victorian small to medium sized enterprises (SMEs). The program builds on an earlier pilot program, developed in consultation with the health industry sector, to effectively target health services. Read more about the pilot program at the Smart SMEs Market Validation Program page.
What will the program deliver?
The program will provide support for Victorian public health sector organisations to collaborate with innovative SMEs to develop new health technology related products, processes or services to a validation point where they are ready for final-stage investment to reach the market.
These purpose-developed technologies will have the potential to deliver:
- improved healthcare and more productive healthcare service delivery (e.g. faster treatment times, reduced cost of treatment, reduced hospital stays)
- economic benefit for the State through supporting SMEs to bring products to market.
Who benefits?
Victorian public health sector organisations
The program provides support to collaborate with industry to develop technology solutions that will improve health or healthcare service delivery and reduce costs.
SMEs
The program provides a new source of funding to develop products, processes or services and the opportunity to develop and validate new technology in response to a real customer demand. In so doing, it offers a sound position from which to secure further investment and commercial opportunities.
The Victorian community
The Victorian community will benefit from improved public sector health service delivery and productivity, early access to new and innovative technologies with the capacity to improve the health and wellbeing of Victorians and more focused private sector R&D, leading to new business ventures and economic benefits.
Which health-sector agencies are eligible?
Victorian health-focused public sector controlled agencies are eligible to apply to develop a Technology Requirement Specification (TRS). Eligible entities are defined under ‘Health Department’ pp 211-213 of the Victorian Department of Treasury and Finance 2010 -11 Financial Report -Chapter 4 -Controlled Entities.
Lead agencies, or a collaborating partner, must have an established clinical research governance mechanism and the capability to trial the product or process during or after the funding period.
Which SMEs can apply?
Victorian-based SMEs may now apply. Larger companies operating in Victoria or with R&D facilities located in Victoria may participate as non-leading collaborative partners. At least 80% of the R&D work must be undertaken in Victoria for the duration of the project.
Selection Criteria
All Health MVP project applications will be assessed against the following criteria:
| Criteria | |
| Economic Impact | Magnitude of benefit to the SME and wider economy |
| Cost of Problem / Productivity Impact | -Magnitude of benefit to health agencies and Victoria-Innovation |
| Strategic Alignment | -Need for Support / Role for Government-Strategic Alignment with Host’s Priorities |
| Capability of the Host and SME | -Project management and delivery capabilities-Governance |
| Procurement Potential / Investment Ready | -Future procurement potential-Investment Ready |
More Information
Health MVP Frequently Asked Questions (FAQ)
Victorian health agencies, SMEs and other interested parties may register to receive further information and updates by completing the Health MVP – Registration of Interest form.
To find out how Treadstone can help with your application call us on (03) 9008 5937 or email us
